Osman et al. Meat MSSA, MRSA, MS-NSA, MR-NSA


TABLE 5 | Antibiotic resistance phenotype and genotype patterns.


Staphylococcus spp. Resistance pattern Number of antibiotics Resistance Genes


mecA gyrA grlA gyrB cfr


S. aureus (n = 9) P, CN, E, DA, VA, SXT 6 +


P, OX, CN, DA, TE, DA, SXT, CIP 8 + +


P, MET, CN, E, DA, TE, SXT, CIP 8 + +


P, OX, CN, DA, TE, VA, SXT, CIP 8 + + +


P, OX, MET, CN, E, DA, TE, SXT, CIP 9 + +


P, OX, MET, CN, E, DA, C, TE, VA, SXT, CIP 11 + + +


P, OX, MET, CN, E, DA, C, TE, VA, SXT, CIP 11 + + +


P, OX, MET, SAM, CN, E, DA, C, VA, SXT, CIP 11 + + + +


P, OX, MET, SAM, CN, E, DA, C, TE, VA, SXT, CIP 12 + + + +


S. hyicus (n = 10) P, VA, SXT, CIP 4 + +


CN, E, DA, C, TE, SXT 6


P, OX, MET, CN, DA, SXT 6


P, OX, MET, CN, DA, SXT 6 +


CN, DA, TE, VA, SXT, CIP 6 + +


P, CN, DA, TE, VA, SXT, CIP 7 + +


P, OX, CN, DA, VA, SXT, CIP 7 + +


P, OX, MET, CN, DA, TE, VA, SXT 8 +


P, OX, MET, CN, DA, TE, VA, SXT, CIP 9 + + + +


P, OX, MET, CN, DA, TE, VA, SXT, CIP 9 + + + +


S. intermedius (n = 3) P, OX, CN, DA, VA, SXT 6


P, OX, CN, E, DA, TE, VA, SXT, CIP 9 + + +


P, OX, MET, CN, E, DA, VA, SXT, C, TE, CIP 11 + + +


S. schleiferi subsp. Coagulans (n = 4) P, OX, MET, CN, DA, SXT, CIP 7 + +


P, OX, MET, SAM, CN, DA, SXT 7 + +


P, OX, MET, CN, E, DA, C, TE, VA, SXT 10 +


P, OX, MET, CN, E, DA, C, TE, VA, SXT 10 +


S. lentus (n = 1) P, OX, MET, SAM, CN, E, DA, TE, VA, SXT, CIP 11 + +


Total (n = 27) 11/27 17/27 19/27 7/27 2/27


C, Chloramphenicol; CIP, Ciprofloxacin; CN, Gentamycin; DA, Clindamycin; E, Erythromycin; MET, Methicillin; OX, Oxacillin; P, Peniciilin; SAM, Ampicillin-sulbactam;
SXT, Sulfamethoxazole/Trimethoprim; TE, Tetracycline; VA, Vancomycin.



2010; Doyle et al., 2013) due to sample collection schemes,
sample types, their minimum capability to implement AMR
surveillance, rock-bottom financial and technical resources and
differences in the implemented methodologies in the form of
credibility, duplicability, enequitable significance **,** price, duration
and simplicity (Strommenger et al., 2006; Cookson et al., 2007;
Faria et al., 2008; Vindel et al., 2009; David et al., 2013) which
makes any comparative effort to be unadvisable.
A wide dispersion of two categories of resistance has been
revealed in the present investigation: 100% of our isolates carried
the QRDRs responsible for quinolone resistance genes (gyrA and
grlA) (17/27, 63% and 19/27, 70.4%) and the mecA resistance
determinant (11/27, 40.7%), responsible for the methicillin and
oxacillin resistance ( **Table 5** ). The mecA determinant has caused



severe complications during the treatment MRSA in humans
(Lee, 2003) and for S. epidermidis infections too (Kitao, 2003)
when the hypothesis that, mecA is transferred from non-S. aureus
staphylococci to S. aureus (Grundmann et al., 2006; Bhargava and
Zhang, 2014) is taken into consideration.
The French National Monitoring Program (RESABO)
established evidence that S. aureus is more susceptible to
antimicrobial drugs than non-S. aureus species (Werckenthin
et al., 2001). Conversely, our results had a commensurate
regular and sequence discernible in the antibiotic resistance
genes between S. aureus and non-S. aureus isolates. The
results showed a congruity between phenotypic resistance and
molecular genotyping for oxacillin, QRDRs, and PhLOPSA
phenotypes. Generally, our results are in assonance with



[Frontiers in Microbiology | www.frontiersin.org](http://www.frontiersin.org/Microbiology) 8 [February 2016 | Volume 7 | Article 222](http://www.frontiersin.org/Microbiology/archive)


